CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MorphoSys US, Inc.

MOR
N/A

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for MOR. That does not mean none is planned.

Get an email about MOR's next catalysts

Track MorphoSys US (MOR) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQHealthcareπŸ‡ΊπŸ‡ΈNorth America
Drug Pipeline

Frequently asked questions

What is in MorphoSys US, Inc.'s drug pipeline?β†’

CatalystAlert tracks 5 drug candidates in MorphoSys US, Inc.'s (MOR) pipeline across Phase 2. Its lead program is MOR00208 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is MorphoSys US, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for MorphoSys US, Inc. (MOR) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track MOR biotech catalysts?β†’

Add MOR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MorphoSys US, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply